Increased risk of limphoproliferative disorders in relatives of B-CLL patients.

被引：0
|
作者：
Capalbo, S
Trerotoli, P
Ciancio, A
Mele, G
Serio, G
Liso, V
机构：
[1] Univ Bari, Chair Hematol, Bari, Italy
[2] Univ Bari, Chair Stat, Bari, Italy
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4124
引用
收藏
页码：260B / 261B
页数：2
相关论文
共 50 条
  • [1] B-CLL in 'young' patients. Analysis on 100 patients
    Desablens, B
    Garidi, R
    Lamour, C
    Tabuteau, S
    Fernandes, J
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 194 - 194
  • [2] Constitutive activation of NFκB2 in a subset of B-CLL patients.
    Munzert, G
    Stobbe, H
    Schrem, S
    Kirchner, D
    Bergmann, L
    BLOOD, 1998, 92 (10) : 484A - 485A
  • [3] Apoptotic effect of dexamethasone and cyclosporin A in malignant cells of B-CLL patients.
    Cabrelle, A
    Trentin, L
    Dal Zilio, B
    Maschio, N
    Baesso, I
    Facco, M
    Trevisan, T
    Binotto, G
    Agostini, C
    Zambello, R
    Semenzato, G
    BLOOD, 2002, 100 (11) : 354B - 354B
  • [4] Bendamustine versus chlorambucil in treatment-naive B-CLL patients.
    Knauf, WU
    Lissitchkov, T
    Herbrecht, R
    Loscertales, J
    Aldaoud, A
    Merkle, K
    BLOOD, 2004, 104 (11) : 287B - 287B
  • [5] Biological or clinical parameters for assessment of prognosis in B-CLL? Analysis of 156 patients.
    Desablens, B
    Garidi, R
    Tabuteau, S
    Capiod, JC
    Fuentes, V
    Lassoued, K
    BLOOD, 2000, 96 (11) : 273B - 273B
  • [6] Genetic aberrations and response to fludarabine as first line treatment in a serie of B-CLL patients.
    Giraldo, P
    Rubio-Martinez, A
    Recasens, V
    Valganon, M
    Latre, P
    Rubio-Felix, D
    Calasanz, MJ
    Odero, MD
    BLOOD, 2005, 106 (11) : 603A - 603A
  • [7] Immunoglobulin disorders at diagnosis and course of B-chronic lymphocytic leukemia (B-CLL) patients
    Vassilakopoulos, TP
    Angelopoulou, MK
    Gribabis, DA
    Siakantaris, MP
    Boussiotis, VA
    Pangalis, GA
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 457 - 457
  • [8] Prognostic impact of cytogenetics in patients with B-CLL
    Sindelarova, L
    Michalova, K
    Zemanova, Z
    Brezinova, J
    Kurkova, S
    Cmunt, E
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 144 - 144
  • [9] Increased serum levels of soluble Fas in progressive B-CLL
    Osorio, LM
    Aguilar-Santelises, M
    De Santiago, A
    Hachiya, T
    Mellstedt, H
    Jondal, M
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2001, 66 (05) : 342 - 346
  • [10] Aspiration or bone marrow biopsy for assessment of prognosis among B-CLL? Analysis of 400 patients.
    Desablens, B
    Fernandes, J
    Tabuteau, S
    Vaida, I
    Garidi, R
    Gontier, MF
    BLOOD, 2000, 96 (11) : 273B - 273B
12345